Zobrazeno 1 - 6
of 6
pro vyhledávání: '"James, Froeschle"'
Publikováno v:
The Pediatric Infectious Disease Journal. 23:429-435
Young children have the highest incidence of meningococcal infection. Approximately 50% of disease in United States children less than 2 years of age is caused by serogroups C and Y. In the developing world, serogroups A and W-135 cause outbreaks and
Autor:
Bernd H. Belohradsky, Sarah Jow, Andreas Kronwitter, Thomas H. Zink, Johannes G. Liese, James Froeschle, Erika Harzer, Robert Klepadlo, S. Stojanov
Publikováno v:
The Pediatric Infectious Disease Journal. 20:981-988
Objectives.To evaluate the safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid (Biken DTaP) vaccine administered to children 4 to 6 years of age who had previously received four doses of Bi
Publikováno v:
Journal of travel medicine. 11(4)
Although human diploid cell vaccine (HDCV) has been available for over two decades and has a proven record of efficacy, it is very expensive to produce and can only be made in small quantities.In this trial, we compared the safety and immunogenicity
Autor:
James King, Margaret B. Rennels, Ryall Robert P, James Froeschle, Susan Manoff, Thomas Papa, Andrea Weddle
Publikováno v:
The Pediatric infectious disease journal. 21(10)
Two injections of tetravalent (Groups A, C, Y and W-135) meningococcal polysaccharide vaccine conjugated to diphtheria were given to 30 toddlers at dosages of 1, 4 and 10 microg/ml polysaccharide of each serogroup. Reactogenicity was acceptable at al
Publikováno v:
The Pediatric infectious disease journal. 21(8)
Since 1997 diphtheria-tetanus toxoids-acellular pertussis (DTaP) vaccines have been recommended for the five dose pertussis vaccination series. To assess rates of medically attended injection site reactions (ISRs), seizures, allergic responses and fe
Autor:
S. Stojanov, Carlton Meschievitz, Frank Porter, James Froeschle, Phil Hosbach, Jörg E. Hoppe, Kii Niinivaara, Johannes G. Liese, Bernd H. Belohradsky, Erika Harzer, Alexander M. Walker
Publikováno v:
The Pediatric infectious disease journal. 16(11)
This case-control study investigated the protective efficacy against pertussis of three doses of a two-component acellular pertussis vaccine (manufactured by Biken in Japan) combined with diphtheria and tetanus toxoids (manufactured by Connaught Labo